title: Reply: Based on the available randomized trial patients should say no to glutathione for Parkinson's disease.
authors.forename: Michael S
authors.initials: MS
authors.lastname: Okun
authors.forename: Anthony
authors.initials: A
authors.lastname: Lang
authors.forename: Joseph
authors.initials: J
authors.lastname: Jankovic
mesh_terms: D006801:Humans; D005978:Glutathione / Q000009:adverse effects; D010300:Parkinson Disease / Q000188:drug therapy; D016032:Randomized Controlled Trials as Topic
chemical_list: D005978:Glutathione